Surgical Innovations Group Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Surgical Innovations Group şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Jul 11

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Apr 19

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Dec 29

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Sep 07

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

May 26

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: SUN şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: SUN şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Surgical Innovations Group Piyasaya Karşı Temettü Getirisi

SUN temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (SUN)	n/a
Pazarın Alt %25'i (GB)	2.1%
Pazarın En İyi %25'i (GB)	5.8%
Sektör Ortalaması (Medical Equipment)	2.6%
Analist tahmini (SUN) (3 yıla kadar)	n/a

Önemli Temettü: SUN şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, SUN şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: SUN şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: SUN herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Surgical Innovations Group Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

First half 2024 earnings released: UK£0.001 loss per share (vs UK£0 in 1H 2023)

New major risk - Financial position

Surgical Innovations Group plc to Report First Half, 2024 Results on Sep 30, 2024

Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Surgical Innovations Group plc, Annual General Meeting, Jun 17, 2024

New major risk - Share price stability

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Full year 2023 earnings released

Surgical Innovations Group plc to Report Fiscal Year 2023 Results on Apr 18, 2024

New minor risk - Financial data availability

New minor risk - Share price stability

Surgical Innovations Group plc Announces Intention of Paul Hardy to Step Down from Position of Independent Non-Executive Director

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Charmaine Day Notifies the Board of Her Intention to Step Down from Her Role as Chief Financial Officer of Surgical Innovations Group plc

Surgical Innovations Group plc Announces Board Change

First half 2023 earnings released: EPS: UK£0 (vs UK£0 in 1H 2022)

Surgical Innovations Group plc to Report First Half, 2023 Results on Sep 19, 2023

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Surgical Innovations Group plc, Annual General Meeting, Jun 27, 2023

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

Surgical Innovations Group plc Appoints Jonathan Glenn as Senior Independent Non-Executive Director and Chairman-Designate

Full year 2022 earnings released: EPS: UK£0 (vs UK£0 in FY 2021)

Surgical Innovations Group plc Provides Revenue Guidance for the Year Ended 31 December 2022

Less than half of directors are independent

First half 2022 earnings released: EPS: UK£0 (vs UK£0 in 1H 2021)

Surgical Innovations Group plc to Report First Half, 2022 Results on Sep 21, 2022

Surgical Innovations Group plc Ordinary Shares to Be Deleted from OTC Equity

Surgical Innovations Group plc Provides Revenue Guidance for the Six Months to 30 June 2022

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Surgical Innovations Group plc, Annual General Meeting, Jun 27, 2022

Price target decreased to UK£0.033

Less than half of directors are independent

Surgical Innovations Group plc Provides Revenue Guidance for the Full Year 2021

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Full year 2020 earnings released: UK£0.004 loss per share (vs UK£0.003 loss in FY 2019)

Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

Full year 2020 earnings released: UK£0.004 loss per share (vs UK£0.003 loss in FY 2019)

Surgical Innovations Group plc to Report Fiscal Year 2020 Results on Mar 25, 2021

Surgical Innovations Group plc Announces New USA Distribution Agreement with Microline Surgical Inc

Surgical Innovations Group plc Announces Adam Power Will Retire as Group Development Director, with Effect from 31 December 2021

Surgical Innovations Group plc Announces Distribution Agreement with Adler Instrument Company Inc

Surgical Innovations Group plc Announces its Collaboration with the Centre for Sustainable Healthcare

First half earnings released

Surgical Innovations Group plc to Report First Half, 2020 Results on Sep 08, 2020

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin